CANCER SCIENCE INSTITUTE OF SINGAPORE

Organization name
CANCER SCIENCE INSTITUTE OF SINGAPORE


Results 961-980 of 1943 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
9612016Lack of phenotypical and morphological evidences of endothelial to hematopoietic transition in the murine embryonic head during hematopoietic stem cell emergenceIizuka K.; Yokomizo T.; Watanabe N.; Tanaka Y.; Osato M. ; Takaku T.; Komatsu N.
9622008Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjectsKelly, R.; Poo, Yeo K.; Teng, L.; Wise, S. ; Isaac, H. ; Lee, C.-Y. ; Huang, S.H. ; Halliwell, B. 
9631-Dec-2007Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4α, and constitutive androstane receptor with docetaxel pharmacokineticsTham, L.-S.; Holford, N.H.G.; Hor, S.-Y.; Tan, T. ; Wang, L. ; Lim, R.-C.; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.
964Dec-2012KRAS mutation analysis in a complex molecular diagnostic referral practice: The need for test redundancyPang, B.; Ong, C.-W. ; Chong, M.-L.; Muliana-Ismail, T.; Soong, R. ; Salto-Tellez, M. 
965Aug-2011KRAS mutation analysis as a diagnostic toolYan, B.; Chin, S.Y. ; Ismail, T.M.; Salto-Tellez, M. 
96616-Apr-2013KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre studyVan Grieken, N.C.T.; Aoyma, T.; Chambers, P.A.; Bottomley, D.; Ward, L.C.; Inam, I.; Buffart, T.E.; Das, K. ; Lim, T.; Pang, B.; Zhang, S.L.; Tan, I.B.; Carvalho, B.; Heideman, D.A.M.; Miyagi, Y.; Kameda, Y.; Arai, T.; Meijer, G.A.; Tsuburaya, A.; Tan, P. ; Yoshikawa, T.; Grabsch, H.I.
967Dec-2011KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinomaPang, N.K.B.; Nga, M.E.; Chin, S.Y. ; Ismail, T.M.; Lim, G.L.; Soong, R. ; Salto-Tellez, M. 
9682010Knockout of the folate transporter folt-1 causes germline and somatic defects in C. elegansAustin, M.U; Liau, W.-S ; Balamurugan, K; Ashokkumar, B; Said, H.M; Lamunyon, C.W
9692016Knockdown of POLA2 increases gemcitabine resistance in lung cancer cellsKoh, V; Kwan, H.Y; Tan, W.L; Mah, T.L; Yong, W.P 
970Feb-2013KIT gene mutation analysis in solid tumours: Biology, clincial applications and trends in diagnostic reportingTay, C.M.; Ong, C.W. ; Lee, V.K.M.; Pang, B.
9712017Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targetsKanojia, D ; Garg, M ; Martinez, J; Anand, M.T ; Luty, S.B; Doan, N.B; Said, J.W; Forscher, C; Tyner, J.W; Koeffler, H.P 
9722016KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancerLiu, Y.-Z; Yang, H; Cao, J; Jiang, Y.-Y ; Hao, J.-J; Xu, X; Cai, Y; Wang, M.-R
97315-Nov-2012Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancerPrasannan, R.; Kalesh, K.A.; Shanmugam, M.K. ; Nachiyappan, A.; Ramachandran, L.; Nguyen, A.H.; Kumar, A.P. ; Lakshmanan, M.; Ahn, K.S.; Sethi, G.
974Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
97523-May-2012JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancerLee, Y.F.; Miller, L.D.; Chan, X.B.; Black, M.A.; Pang, B.; Ong, C.W. ; Salto-Tellez, M. ; Liu, E.T.; Desai, K.V.
9762018JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMansour, M.R; He, S; Li, Z; Lobbardi, R; Abraham, B.J; Hug, C; Rahman, S; Leon, T.E; Kuang, Y.-Y; Zimmerman, M.W; Blonquist, T; Gjini, E; Gutierrez, A; Tang, Q; Garcia Perez, L; Pike Overzet, K; Anders, L; Berezovskaya, A; Zhou, Y; Zon, L.I; Neuberg, D; Fielding, A.K; Staal, F.J.T; Langenau, D.M; Sanda, T ; Young, R.A; Look, A.T
9771-Oct-2021Janus Kinase Signaling: Oncogenic Criminal of Lymphoid CancersLi, Boheng; Wan, Qin; Li, Zhubo; Chng, Wee-Joo 
181-Dec-2020Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialDimopoulos, Meletios A; Spicka, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo ; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria-Victoria; Morgan, Gareth; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagar
192010ITIH3 Is a potential biomarker for early detection of gastric cancerChong, P.K. ; Lee, H.; Zhou, J. ; Liu, S.-C.; Loh, M.C.S. ; Wang, T.T. ; Lim, Y.P. ; Chan, S.P.; Smoot, D.T.; Ashktorab, H.; So, J.B.Y. ; Lim, K.H.; Yeoh, K.G. 
20Feb-2011Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in miceXiang, W. ; Ke, Z. ; Zhang, Y. ; Ho-Yuet Cheng, G.; Irwan, I.D.; Sulochana, K.N. ; Potturi, P. ; Wang, Z.; Yang, H.; Wang, J.; Zhuo, L.; Kini, R.M. ; Ge, R.